利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

19 条记录 (耗时 0.027 秒)

    SELF-DIAGNOSIS SYSTEM AND TEST CIRCUIT DETERMINATION METHOD
    2.
    发明申请
    SELF-DIAGNOSIS SYSTEM AND TEST CIRCUIT DETERMINATION METHOD 有权
    自诊断系统和测试电路确定方法

    公开(公告)号：US20110264972A1

    公开(公告)日：2011-10-27

    申请号：US13086852

    申请日：2011-04-14

    申请人： Masafumi MATSUO

    发明人： Masafumi MATSUO

    IPC分类号： G06F11/00

    CPC分类号： G01R31/31724 ,  G01R31/3187

    摘要： Provided are a self-diagnosis system and a test circuit determination method that are capable of determining normality of a test circuit which diagnoses a test target circuit. A self-diagnosis system according to an aspect of the present invention includes a test circuit including first and second diagnosis controllers which determine normality of a test target circuit by using an execution result of a test pattern in the test target circuit; and a test circuit determination unit which determines normality of the test circuit by comparing a normality determination result of the test target circuit output from the first diagnosis controller with a normal determination result of the test target circuit output from the second diagnosis controller.

    摘要翻译： 提供了能够确定诊断测试对象电路的测试电路的正常性的自诊断系统和测试电路确定方法。 根据本发明的一个方面的自诊断系统包括：测试电路，包括第一诊断控制器和第二诊断控制器，其通过使用测试目标电路中的测试图案的执行结果来确定测试对象电路的正常性; 以及测试电路确定单元，通过将从第一诊断控制器输出的测试目标电路的正常判定结果与从第二诊断控制器输出的测试对象电路的正常确定结果进行比较来确定测试电路的正常性。

    Prophylactic or Ameliorating Agent for Genetic Diseases
    5.
    发明申请
    Prophylactic or Ameliorating Agent for Genetic Diseases 有权
    遗传疾病预防或改善剂

    公开(公告)号：US20130102644A1

    公开(公告)日：2013-04-25

    申请号：US13805151

    申请日：2011-06-27

    申请人： Masatoshi Hagiwara ,  Masafumi Matsuo ,  Naoyuki Kataoka ,  Atsushi Nishida

    发明人： Masatoshi Hagiwara ,  Masafumi Matsuo ,  Naoyuki Kataoka ,  Atsushi Nishida

    IPC分类号： A61K31/428

    CPC分类号： A61K31/428 ,  C07D277/64 ,  C07K14/4707 ,  C07K14/4708 ,  C12N9/12

    摘要： An object of the present invention is to provide a prophylactic or ameliorating agent for a genetic disease that is caused by a mutation in an exon of a gene and is capable of forming a functional truncated protein by skipping of the exon comprising the mutation. The prophylactic or ameliorating agent used in the present invention is a prophylactic or ameliorating agent for a genetic disease that is caused by a mutation in an exon of a gene and is capable of forming a functional truncated protein by skipping of the exon comprising the mutation, wherein the prophylactic or ameliorating agent contains a compound having a molecular weight of 1500 or lower.

    摘要翻译： 本发明的目的是提供由基因外显子突变引起的遗传疾病的预防或改善剂，并且能够通过跳过包含突变的外显子形成功能性截短的蛋白质。 用于本发明的预防或改善剂是由基因外显子突变引起的遗传疾病的预防或改善剂，能够通过跳过包含突变的外显子形成功能性截短蛋白， 其中所述预防或改善剂含有分子量为1500以下的化合物。

    Medicament for treatment of Duchenne muscular dystrophy
    7.
    发明授权
    Medicament for treatment of Duchenne muscular dystrophy 有权
    杜氏肌营养不良药物

    公开(公告)号：US06653467B1

    公开(公告)日：2003-11-25

    申请号：US09667327

    申请日：2000-09-22

    申请人： Masafumi Matsuo ,  Yasuhiro Takeshima

    发明人： Masafumi Matsuo ,  Yasuhiro Takeshima

    IPC分类号： C07H2104

    CPC分类号： C12N15/113 ,  A61K38/00 ,  A61K48/00 ,  C12N2310/11 ,  C12N2310/315

    摘要： Antisense oligonucleotides comprising a nucleotide sequence complementary to the nucleotide sequence of SEQ ID NO:1 or NO:2 are disclosed. The antisense oligonucleotides are used for treatment of specific types of Duchenne muscular dystrophy which is attributed to a change in number of the nucleotides composing one or more exons adjacent to exon 43 or 53, respectively, in human dystrophin mRNA, wherein the change is due to deletion of one or more nucleotides from the normal nucleotide sequence for the exons, wherein the net of the change in number of the nucleotides is expressed as a reduction of (3×N+1) nucleotides, wherein N is zero or a natural number.

    摘要翻译： 公开了包含与SEQ ID NO：1或NO：2的核苷酸序列互补的核苷酸序列的反义寡核苷酸。 反义寡核苷酸用于治疗特定类型的Duchenne肌营养不良症，其归因于构成人肌营养不良蛋白mRNA中分别与外显子43或53相邻的一个或多个外显子的核苷酸数量的变化，其中变化是由于 从外显子的正常核苷酸序列中删除一个或多个核苷酸，其中核苷酸数量变化的净值表示为（3×N + 1）核苷酸的减少，其中N为零或自然数。

    Self-diagnosis system and test circuit determination method
    9.
    发明授权
    Self-diagnosis system and test circuit determination method 有权
    自诊断系统和测试电路的确定方法

    公开(公告)号：US08719650B2

    公开(公告)日：2014-05-06

    申请号：US13086852

    申请日：2011-04-14

    申请人： Masafumi Matsuo

    发明人： Masafumi Matsuo

    IPC分类号： G01R31/28

    CPC分类号： G01R31/31724 ,  G01R31/3187

    摘要： Provided are a self-diagnosis system and a test circuit determination method that are capable of determining normality of a test circuit which diagnoses a test target circuit. A self-diagnosis system according to an aspect of the present invention includes a test circuit including first and second diagnosis controllers which determine normality of a test target circuit by using an execution result of a test pattern in the test target circuit; and a test circuit determination unit which determines normality of the test circuit by comparing a normality determination result of the test target circuit output from the first diagnosis controller with a normal determination result of the test target circuit output from the second diagnosis controller.

    摘要翻译： 提供了能够确定诊断测试对象电路的测试电路的正常性的自诊断系统和测试电路确定方法。 根据本发明的一个方面的自诊断系统包括：测试电路，包括第一诊断控制器和第二诊断控制器，其通过使用测试目标电路中的测试图案的执行结果来确定测试对象电路的正常性; 以及测试电路确定单元，通过将从第一诊断控制器输出的测试目标电路的正常判定结果与从第二诊断控制器输出的测试对象电路的正常确定结果进行比较来确定测试电路的正常性。